Stocks and Investing Stocks and Investing
Mon, November 20, 2023

Raghuram Selvaraju Reiterated (SPRB) at Strong Buy and Held Target at $10 on, Nov 20th, 2023


Published on 2024-10-28 07:40:06 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Spruce Biosciences, Inc." (SPRB) at Strong Buy and Held Target at $10 on, Nov 20th, 2023.

Raghuram has made no other calls on SPRB in the last 4 months.



There are 4 other peers that have a rating on SPRB. Out of the 4 peers that are also analyzing SPRB, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Raghuram


  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $8 on, Wednesday, September 13th, 2023
  • Joseph Schwartz of "SVB Leerink" Upgraded from Hold to Buy and Increased Target to $9 on, Friday, September 8th, 2023
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Decreased Target to $7 on, Friday, August 18th, 2023
  • Jonathan Wolleben of "JMP Securities" Maintained at Buy with Increased Target to $8 on, Wednesday, August 16th, 2023
Contributing Sources